$MOH (Molina Healthcare, Inc.)

$MOH {{ '2015-11-30T23:00:04+0000' | timeago}} • Announcement

$MOH said that it has agreed to acquire Better Health Network in Cook County, Illinois and assume certain assets related to the operation of Better Health's Medicaid business. $MOH will fund the deal with available cash. Subject to regulatory approvals & satisfaction of other conditions, the closing of the transaction is expected to occur in 2Q16.

$HUM {{ '2018-01-16T20:57:20+0000' | timeago}} • Announcement

Healthcare company $HUM has appointed Luis Torres Olivera as President, Health and Well-being, for the Puerto Rico Market. Torres Olivera, who joined the company more than a decade ago, has overseen several key projects. He succeeds Earl Harper, who will be retiring at the end of February 2018.

$UNH {{ '2018-01-16T17:58:43+0000' | timeago}} • Infographic

$UNH UnitedHealth Group Incorporated Earnings AlphaGraphic: Q4 2017 Highlights

$MOH {{ '2018-01-11T21:46:24+0000' | timeago}} • Announcement

$MOH said COO Terry Bayer will be retiring in the next several weeks. The corporate COO role will no longer be a part of $MOH's organizational structure. This is consistent with the company's shift to a flatter organizational structure that will enable the CEO to be more directly involved with business and health plan operations.

$SYK {{ '2018-01-09T17:21:37+0000' | timeago}} • Announcement

$SYK said that for 4Q17 its preliminary results are of net sales growth of 10% to $3.5Bil, while for FY17, its net sales grew 9.9% to $12.4Bil. Excluding the impact of foreign currency & acquisitions, net sales rose 8.1% and 7.1% in 4Q17 and FY17. For 2018, $SYK expects modest headwinds that will be manageable within its overall financial targets.

$AGN {{ '2018-01-09T15:46:35+0000' | timeago}} • Announcement

$AGN, which announced its plan to give pink slips to 1,000 of its employees and cut down 400 open positions earlier this year, provided FY18 financial outlook. In 2018, Allergan plans to sell its remaining position of 10% stake in $TEVA through Forward Sale Agreements and/or open market sales.

$LLY {{ '2018-01-08T19:33:20+0000' | timeago}} • Announcement

$LLY join hands with consumer digital health company Livongo Health to study real world behaviors of people affected with diabetes. This collaboration is expected help the diabetic people to better manage their condition.

$AMAG {{ '2018-01-08T15:32:45+0000' | timeago}} • Announcement

Pharma firm $AMAG said it expects double-digit revenue growth in fiscal 2017, and strong bottomline cash generation. The company expects 4Q17 revenues to be between $155MM and $162MM, and sees an operating loss of $6-$16MM. FY17 revenue is estimated to be in the $607-$614MM range. Full year operating loss is forecasted between $292MM and $302MM.

$OMI {{ '2018-01-05T13:04:48+0000' | timeago}} • Announcement

Healthcare solutions firm $OMI plans to organize into two units, named Global Solutions and Global Products. The move is in connection with the acquisition and integration of Halyard Health’s Surgical & Infection Prevention business. Global Solutions will contain most of Owens’ legacy business, while Global Products will contain its S&IP business.

$AGN {{ '2017-12-26T12:22:55+0000' | timeago}} • Announcement

$AGN said that the Federal Circuit confirmed that a proposed generic version of Combigan eye drug from Sandoz, a unit of $NVS, did not infringe Allergan's two patents. The Federal Circuit also reversed the district court's decision that Sandoz's proposed generic product infringes Allergan's 3rd patent. Allergan plans to file for rehearing within 30 days.

$DXC {{ '2017-12-22T12:13:53+0000' | timeago}} • Announcement

$DXC said Meg Whitman, chief executive officer of $HPE, will step down from the company's board of directors. He had joined the $DXC board earlier this year.

$ANTM {{ '2017-12-21T19:37:12+0000' | timeago}} • Announcement

$ANTM completed the acquisition of Florida-based HealthSun, that provides managed healthcare plans. Financial terms of the deal remained undisclosed. With the addition of HealthSun, $ANTM's affiliated Medicare and Medicaid plans now serve more than 650,000 consumers in Florida. This deal is expected to be slightly accretive to earnings in 2018.

$AGN {{ '2017-12-21T14:38:43+0000' | timeago}} • Announcement

$AGN and its partner $PRTK announced that FDA accepted to review Seysara, an investigational drug for treating acne. Allergan, which has the U.S. rights of developing and marketing Seysara, expects FDA to take action on this in 2H18. Paratek retains the non-U.S. rights. In March 2017, Allergan announced positive results from Seysara Phase 3 trials.

$ABBV {{ '2017-12-21T13:23:43+0000' | timeago}} • Announcement

$ABBV announced positive top-line results from the Phase 3 SELECT-MONOTHERAPY clinical trial. Upadacitinib is not approved by regulatory authorities and its safety and efficacy have not been established.

$HUM {{ '2017-12-19T15:27:46+0000' | timeago}} • Announcement

$HUM signed a definitive agreement to acquire a 40% minority interest in the Kindred at Home Division of $KND for an estimated cash consideration of approximately $800MM. Humana does not anticipate a material impact to earnings in 2017 from this pending transaction.

$KND {{ '2017-12-19T13:44:51+0000' | timeago}} • Announcement

$KND's BoD approved a definitive agreement whereby it will be acquired by a consortium of three companies: TPG Capital, Welsh, Carson, Anderson & Stowe and $HUM for about $4.1Bil in cash including the assumption or repayment of net debt. The transaction is expected to close during the summer of 2018.

$AGN {{ '2017-12-18T22:26:29+0000' | timeago}} • Announcement

Robert Stewart, COO of $AGN will resign from his role. He has been named as the CEO of the newly formed Amneal Pharmaceuticals, effective Jan. 25, 2018. Following Rob's departure, Wayne Swanton, SVP, Global Operations has been promoted as EVP, Global Operations of Allergan.

$AGN {{ '2017-12-18T22:14:14+0000' | timeago}} • Announcement

$AGN and its development partner Gedeon Richter Plc reported positive results from phase 3 study of cariprazine, which is used to treat the bipolar depression. Allergan plans to file the New Drug Application to the FDA in 2H18.

$IPXL {{ '2017-12-18T13:05:53+0000' | timeago}} • Announcement

Amneal Pharmaceuticals LLC and $IPXL said Robert Stewart will join Amneal as President, effective Jan. 25, 2018. Stewart most recently served as COO of $AGN. After completion of combination of Amneal and $IPXL, Stewart will become President and CEO of the combined company, to be named Amneal Pharmaceuticals Inc., and will become a BoD member.

$CI {{ '2017-12-15T12:13:02+0000' | timeago}} • Announcement

$CI acquired Brighter Inc., a platform that connects patients, providers, and payers. $CI expects Brighter’s digital health plan platform will help to accelerate and expand the consumer initiatives. The financial details of the deal remained undisclosed.

$LLY {{ '2017-12-14T18:20:39+0000' | timeago}} • Announcement

$LLY join hands with diabetes management firm Rimidi to provide personalized solutions for diabetic patients who are using insulin. As per the agreement, Rimidi's diabetes management software platform will be integrated with Lilly's insulin management system which is in development.

Recent Transcripts

UNH (UnitedHealth Group Incorporated)
Tuesday, January 16 2018 - 1:45pm
ENZ (Enzo Biochem Inc.)
Friday, December 8 2017 - 1:30pm
GTS (Triple-S Management Corporation)
Thursday, November 9 2017 - 2:00pm
HUM (Humana Inc.)
Wednesday, November 8 2017 - 2:00pm
DXC (DXC Technology Company)
Tuesday, November 7 2017 - 10:00pm
ZIOP (ZIOPHARM Oncology, Inc.)
Monday, November 6 2017 - 9:30pm
VCYT (Veracyte, Inc.)
Monday, November 6 2017 - 9:30pm
MOH (Molina Healthcare, Inc.)
Thursday, November 2 2017 - 9:00pm
CYH (Community Health Systems, Inc.)
Thursday, November 2 2017 - 3:00pm
CI (Cigna Corp.)
Thursday, November 2 2017 - 12:30pm
AMAG (AMAG Pharmaceuticals, Inc.)
Thursday, November 2 2017 - 12:00pm
TEVA (Teva Pharmaceutical Industries Limited)
Thursday, November 2 2017 - 12:00pm
MGLN (Magellan Health, Inc.)
Wednesday, November 1 2017 - 2:00pm
AGN (Allergan plc)
Wednesday, November 1 2017 - 12:30pm
OMI (Owens & Minor Inc.)
Wednesday, November 1 2017 - 12:00pm
WCG (WellCare Health Plans, Inc.)
Tuesday, October 31 2017 - 1:30pm
AET (Aetna Inc.)
Tuesday, October 31 2017 - 12:30pm
ABBV (AbbVie Inc.)
Friday, October 27 2017 - 1:00pm
SYK (Stryker Corporation)
Thursday, October 26 2017 - 8:30pm
LH (Laboratory Corp. of America Holdings)
Wednesday, October 25 2017 - 1:00pm

AlphaGraphics you may like